Journal
LANCET
Volume 380, Issue 9844, Pages 848-857Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(12)60605-9
Keywords
-
Categories
Funding
- Seattle Genetics
- Roche
- Genentech
Ask authors/readers for more resources
Lymphomas are solid tumours of the immune system. Hodgkin's lymphoma accounts for about 10% of all lymphomas, and the remaining 90% are referred to as non-Hodgkin lymphoma. Non-Hodgkin lymphomas have a wide range of histological appearances and clinical features at presentation, which can make diagnosis difficult. Lymphomas are not rare, and most physicians, irrespective of their specialty, will probably have come across a patient with lymphoma. Timely diagnosis is important because effective, and often curative, therapies are available for many subtypes. In this Seminar we discuss advances in the understanding of the biology of these malignancies and new, available treatments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available